DNER and breast carcinoma: Although several studies have investigated the impact of BET protein inhibition in breast cancer [29–33], some of them evaluating its impact on epithelial-to-mesenchymal transition [34], little is known about the impact of their associated epigenetic drugs on cancer stemness in this cancer type.